I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Yokoyama, Toshihide
45
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Incidence and impact of interstitial lung disease and malig..:
Ikeda, Satoshi
;
Arita, Machiko
;
Misaki, Kenta
...
http://www.springerplus.com/content/4/1/240. , 2015
Link:
http://www.springerplus...
?
2
Randomized, open-label phase II study of brigatinib and car..:
Kazushige Wakuda
;
Hirotsugu Kenmotsu
;
Yuki Sato
...
https://doi.org/10.1186/s12885-023-11417-w. , 2023
Link:
https://doi.org/10.1186/..
?
3
Pneumonitis associated with pembrolizumab plus chemotherapy..:
Daichi Fujimoto
;
Satoru Miura
;
Keisuke Tomii
...
https://doi.org/10.1038/s41598-023-30676-y. , 2023
Link:
https://doi.org/10.1038/..
?
4
Exploratory analysis of immunochemotherapy compared to chem..:
Tae Hata
;
Chikara Sakaguchi
;
Keita Hirano
...
https://doi.org/10.1111/1759-7714.14836. , 2023
Link:
https://doi.org/10.1111/..
?
5
Liquid biopsy detects genomic drivers in NSCLC without EGFR..:
Takehiro Uemura
;
Hirotsugu Kenmotsu
;
Daisuke Hazama
...
https://doi.org/10.1002/cam4.6668. , 2023
Link:
https://doi.org/10.1002/..
?
6
Real-World Treatments and Clinical Outcomes in Advanced NSC..:
Hiroshi Nokihara
;
Takashi Kijima
;
Toshihide Yokoyama
...
Cancer Therapy. , 2022
Link:
https://doi.org/10.3390/..
?
7
Prospective analysis of factors precluding the initiation o..:
Shigeru Tanzawa
;
Tomonori Makiguchi
;
Sadatomo Tasaka
...
https://doi.org/10.1177/17588359221116603. , 2022
Link:
https://doi.org/10.1177/..
?
8
A new risk-assessment tool for venous thromboembolism in ad..:
Yukari Tsubata
;
Takamasa Hotta
;
Kosuke Hamai
...
https://doi.org/10.1186/s13045-022-01259-7. , 2022
Link:
https://doi.org/10.1186/..
?
9
Hypothyroidism as an immune-related adverse event caused by..:
Masanori Kawataki
;
Yosuke Nakanishi
;
Toshihide Yokoyama
.
http://www.sciencedirect.com/science/article/pii/S2213007122000077. , 2022
Link:
https://doi.org/10.1016/..
?
10
The Effect of Pleural Effusion on Prognosis in Patients wit..:
Tomoka Nishimura
;
Eiki Ichihara
;
Toshihide Yokoyama
...
https://www.mdpi.com/2072-6694/14/24/6184. , 2022
Link:
https://doi.org/10.3390/..
?
11
Real-World Treatments and Clinical Outcomes in Advanced NSC..:
Hiroshi Nokihara
;
Takashi Kijima
;
Toshihide Yokoyama
...
https://www.mdpi.com/2072-6694/14/12/2846. , 2022
Link:
https://doi.org/10.3390/..
?
12
Incidence of venous thromboembolism in advanced lung cancer..:
Yukari Tsubata
;
Takamasa Hotta
;
Kosuke Hamai
...
https://doi.org/10.1177/17588359221110171. , 2022
Link:
https://doi.org/10.1177/..
?
13
The Effect of Pleural Effusion on Prognosis in Patients wit..:
Tomoka Nishimura
;
Eiki Ichihara
;
Toshihide Yokoyama
...
Cancer Immunology and Immunotherapy. , 2022
Link:
https://doi.org/10.3390/..
?
14
Clinical factors associated with shorter durable response, ..:
Kazutaka Hosoya
;
Daichi Fujimoto
;
Takeshi Morimoto
...
https://doi.org/10.1186/s12885-021-08048-4. , 2021
Link:
https://doi.org/10.1186/..
?
15
Crizotinib for recurring non‐small‐cell lung cancer with EM..:
Daijiro Harada
;
Hideko Isozaki
;
Toshiyuki Kozuki
...
https://doi.org/10.1111/1759-7714.13825. , 2021
Link:
https://doi.org/10.1111/..
1-15